Complex formation of Ibuprofen and β-Cyclodextrin by controlled particle deposition (CPD) using SC-CO2

Pace, 1999, Injectable formulations of insoluble drugs, Pharm. Technol., 23, 116 Müller, 1999, Nanosuspensionen—Formulierungenfür schwerlösliche Arzneistoffe mit geringer Bioverfügbarkeit. 1. Mitteilung: Herstellung und Eigenschaften. 2. Mitteilung: Stabilität, biopharmazeutische Aspekte, mögliche Arzneiformen und Zulassungsfragen, Pharm. Ind., 61, 175 Subramaniam, 1997, Pharmaceutical processing with supercritical carbon dioxide, J. Pharm. Sci., 86, 885, 10.1021/js9700661 Jung, 2001, Particle design using supercritical fluids: literature and patent survey, J. Supercrit. Fluids, 20, 179, 10.1016/S0896-8446(01)00064-X Türk, 1999, Formation of small organic particles by RESS: experimental and theoretical investigations, J. Supercrit. Fluids, 15, 79, 10.1016/S0896-8446(98)00131-4 Hils, 2000, Nanoscale particles for pharmaceutical purpose by rapid expansion of supercritical solutions (RESS). Part I. Experiments and modelling. Part II. Characterization of the product and use, Tome 1: Particle Design, Materials and Reactions, 27–32, 53 M. Türk Erzeugung von organischen Nanopartikeln mit überkritischen Fluiden; professorial dissertation, Universität Karlsruhe, TH, 2001. Türk, 2002, Micronization of pharmaceutical substances by rapid expansion of supercritical solutions (RESS): a promising method to improve the bioavailability of poorly soluble pharmaceutical agents, J. Supercrit. Fluids, 22, 75, 10.1016/S0896-8446(01)00109-7 Türk, 2002, Micronization of pharmaceutical substances by rapid expansion of supercritical solutions (RESS): experiments and modelling, Part. Part. Syst. Charact., 19, 327, 10.1002/1521-4117(200211)19:5<327::AID-PPSC327>3.0.CO;2-V H.-J. Martin, Doctoral thesis, Charakterisierung von schwerlöslichen Arzneistoff-Nanopartikeln hergestellt durch das RESS-Verfahren zur Verbesserung der Bioverfügbarkeit; Universität Tübingen (2003). Türk, 2005, In situ characterization of drug nanoparticles by FTIR-spectroscopy, vol. 3 Loftsson, 1999, Pharmaceutical applications of β-cyclodextrin, Pharm. Tech., 23, 40 Loftsson, 1996, Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization, J. Pharm. Sci., 85, 1017, 10.1021/js950534b Van Hees, 1999, Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound, Pharm. Res., 16, 1864, 10.1023/A:1018955410414 Van Hees, 2002, Application of supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds, J. Inclus. Phenom. Macrocyclic Chem., 44, 27, 10.1023/A:1023084617964 Bandi, 2004, Preparation of budesonide- and indomethacin-hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process, Eur. J. Pharm. Sci., 23, 159, 10.1016/j.ejps.2004.06.007 Charoenchaitrakool, 2002, Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin, Int. J. Pharm., 239, 103, 10.1016/S0378-5173(02)00078-9 Türk, 2004, Utilization of supercritical fluid technology for the preparation of innovative carriers loaded with nanoparticular drugs Hussein, 2004, Preparation and evaluation of drug/β-Cyclodextrin solid inclusion complexes by supercritical fluid technology M. Türk, P. Hils, Kh. Hussein, M. Wahl Utilization of supercritical fluid technology for the preparation of innovative carriers loaded with nanoparticular drugs, in: Produktgestaltung in der Partikeltechnologie, Band 2 Fraunhofer IRB Verlag, ISBN 3-8167-6476-2, p. 373. Lemert, 1989, Solid–liquid–gas equilibria in multicomponent supercritical fluid systems, Fluid Phase Equilib., 45, 265, 10.1016/0378-3812(89)80262-6 Diefenbacher, 2002, Phase equilibria of organic solid solutes and supercritical fluids with respect to the RESS process, J. Supercrit. Fluids, 22, 175, 10.1016/S0896-8446(01)00123-1 Waleczek, 2003, Phase solubility studies of pure α-bisabolol and camomile essential oil with β-cyclodextrin, Eur. J. Pharm. Biopharm., 55, 247, 10.1016/S0939-6411(02)00166-2 C. Kaiser, Doctoral thesis, Herstellung, In-Line-Einschluss und Charakterisierung Lipophiler und Hydrophiler Kamillenextrakte unter Einsatz von verdichtetem Kohlendioxid, Universität Tübingen (2003). Stricker, 1969, Die in-vitro-Untersuchungder “Verfügbarkeit von Arzneistoffen” im Gastrointestinaltrakt, Pharm. Ind., 31, 794 Uchida, 2005, Measurement and correlation of the solid–liquid–gas equilibria for the carbon dioxide+S(+)-Ibuprofen and carbon dioxide+S(±)-Ibuprofen systems, J. Chem. Eng. Data, 50, 11, 10.1021/je034228o Peng, 1976, A new two-constant equation of state, Ind. Eng. Chem. Fund., 15, 59, 10.1021/i160057a011 Türk, 2004, Phase behaviour of organic solid solutes and supercritical fluids with respect to particle formation processes, 147 Reid, 1987